New combined cell therapy for kidney transplants can help reduce donor-specific immune response

FHS
July 22, 2024
12:42 pm

A new combined cell therapy for kidney transplants can help to reduce the donor-specific reaction against the transplanted organ without the need for maintenance triple immunosuppression.

Pharmalittle: We’re reading about Lilly lawsuits, Novo Nordisk fires and much more

Rise and shine, everyone, another hot day is on the way. The forecast – at least on this side of the pond – is warning

June 20, 2024

Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer – Biotech Investments

Biophytis / Key word(s): Miscellaneous/Miscellaneous Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer 14-Sep-2023 / 07:00 CET/CEST Biophytis Strengthens

September 15, 2023

Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors

Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are enveloping the Pharmalot campus, where

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.